Your browser does not support iframes.
In the Beginning...
Established in Jerusalem in 1901, the company known today as Teva starts out as a small wholesale drug business that distributes imported medications.
A New Pharmaceutical Industry is FoundedConditions are ripe for establishing a local pharmaceutical industry. New manufacturing plants are founded and quickly gain momentum. During World War II, these plants are the sole source of pharmaceutical supplies for the local market, neighboring countries and the British Army stationed in the Middle East.
Expansion of the Local Drug MarketWith the founding of the State of Israel, the local drug market expands rapidly. Established pharmaceutical manufacturing companies grow, including Teva. While most are privately owned, Teva begins trading on the Tel Aviv Stock Exchange in 1951.
Consolidation of the Local Pharmaceutical IndustryA period of consolidation in the Israeli pharmaceutical industry beginning in the 1960s culminates with the 1976 union of Teva, Assia, and Zori to create Israel’s largest drugmaker, Teva Pharmaceutical Industries Ltd. Teva takes its first step abroad into Europe.
Going International - Worldwide ExpansionTeva expands internationally, capitalizing on the passing of the Hatch-Waxman Act to enter the US market in the generics sector. Teva begins trading on NASDAQ, marking the start of a period of robust growth.
Extending a Strong Multinational PresenceTeva’s first major new drug, Copaxone® for the treatment of Multiple Sclerosis (MS), is approved by the FDA. Teva invests in a series of acquisitions that extend its global reach in the US and Europe. The company assumes leadership of the US generics sector.
A Leader in Global MarketsTeva continues to invest in major acquisitions of Canadian, US and EU pharmaceutical companies with subsidiaries in Latin America and elsewhere. Teva becomes the largest generic pharmaceutical company in North America, and strengthens its worldwide presence while broadening its pipeline and product offerings.
Towards the World’s Most indispensable Medicines CompanyTeva expands operations in Latin America and the Far East, and increases product diversification. Under new leadership, Teva is well-positioned to fulfill its global strategy of becoming the most indispensable medicines company in the world.